These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6976203)

  • 41. Growth stimulation of microenvironment-dependent mouse leukemias by tumor-promoting phorbol esters.
    Hiai H; Nishizuka Y
    J Natl Cancer Inst; 1981 Dec; 67(6):1333-40. PubMed ID: 6975850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor-promoting phorbol esters stimulate C3b and C3b' receptor-mediated phagocytosis in cultured human monocytes.
    Wright SD; Silverstein SC
    J Exp Med; 1982 Oct; 156(4):1149-64. PubMed ID: 7153708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phorbol ester tumor promoter affects the mouse epidermal gap junctions.
    Kalimi GH; Sirsat SM
    Cancer Lett; 1984 Apr; 22(3):343-50. PubMed ID: 6713375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of T leukaemic cell phenotype with phorbol ester.
    Delia D; Greaves MF; Newman RA; Sutherland DR; Minowada J; Kung P; Goldstein G
    Int J Cancer; 1982 Jan; 29(1):23-31. PubMed ID: 6977500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mouse rosette positive B cells fail to synthesize immunoglobulin following incubation with pokeweed mitogen.
    Davey FR; Kurec AS; Lamberson HV
    Clin Exp Immunol; 1983 Dec; 54(3):771-7. PubMed ID: 6606517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alterations in enzyme expression on 12-O-tetradecanoylphorbol-13-acetate-induced differentiation of chronic lymphocytic leukemia cells.
    Srivastava BI; Han T
    FEBS Lett; 1984 May; 170(1):152-6. PubMed ID: 6427005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in a T-cell subpopulation marker induced by tumor-promoting phorbol esters.
    Hurley DJ; Mastro AM
    Carcinogenesis; 1985 Oct; 6(10):1435-40. PubMed ID: 3930084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of the tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate on newly synthesized proteins in mouse epidermis.
    Laskin JD; Mufson RA; Piccinini L; Engelhardt DL; Weinstein IB
    Cell; 1981 Aug; 25(2):441-9. PubMed ID: 6169440
    [No Abstract]   [Full Text] [Related]  

  • 49. Phorbol ester modulation of T-cell antigens in the Jurkat lymphoblastic leukemia cell line.
    Cassel DL; Hoxie JA; Cooper RA
    Cancer Res; 1983 Oct; 43(10):4582-6. PubMed ID: 6603901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion.
    Lotem J; Sachs L
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5158-62. PubMed ID: 291929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between different cell surface markers in chronic lymphocytic leukemia.
    Potomski J; Harłozińska A; Becker M; Noworolska A
    Neoplasma; 1980; 27(3):295-300. PubMed ID: 7453849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spontaneous mouse erythrocyte-rosette formation: correlation with surface immunoglobulin phenotype in hairy-cell leukaemia.
    Burns GF; Cawley JC
    Clin Exp Immunol; 1980 Jan; 39(1):83-9. PubMed ID: 6966990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differentiation between chronic lymphocytic leukaemia (B-CLL) and non-Hodgkin lymphomas in the leukaemic phase by the mouse red blood cell rosette assay.
    Pecze K; Telek B; Kiss A; Rak K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):446-50. PubMed ID: 2431964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of dark keratinocytes by 12-O-tetradecanoylphorbol-13-acetate and mezerein as an indicator of tumor-promoting efficiency.
    Klein-Szanto AJ; Major SK; Slaga TJ
    Carcinogenesis; 1980 May; 1(5):399-406. PubMed ID: 6168406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A subpopulation of human B lymphocytes that rosette with mouse erythrocytes.
    Forbes IJ; Zalewski PD
    Clin Exp Immunol; 1976 Oct; 26(1):99-107. PubMed ID: 1087215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunological studies in chronic lymphocytic leukemia.-I. Elucidation of subset heterogeneity.
    Hokland P; Ellegaard J
    Leuk Res; 1981; 5(4-5):341-8. PubMed ID: 6974810
    [No Abstract]   [Full Text] [Related]  

  • 57. Differentiation of chronic lymphocytic leukemia cells after in vitro treatment with Epstein-Barr virus or phorbol ester. I. Immunologic and morphologic studies.
    Deegan MJ; Maeda K
    Am J Hematol; 1984; 17(4):335-47. PubMed ID: 6093504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional studies on B-cell hybridomas with B-cell surface antigens. III. Differentiative response to phorbol esters.
    Hamano T; Leiserson WM; Asofsky R
    Cell Immunol; 1984 Feb; 83(2):330-9. PubMed ID: 6607129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumour-promoting phorbol diester induces substrate-adhesion and growth inhibition in lymphoblastoid cells.
    Castagna M; Rochette-Egly C; Rosenfeld C
    Cancer Lett; 1979 Apr; 6(4-5):227-34. PubMed ID: 285749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Induced differentiation of subpopulations of leukemic blood cells in patients with chronic B-cell lympholeukemia].
    Zlobina EN; Baryshnikov AIu
    Biull Eksp Biol Med; 1987 Mar; 103(3):340-2. PubMed ID: 3548840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.